Is drug facilitated sexual assault changing? About a case involving 4-bromomethcathinone

Clicks: 6
ID: 319329
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #26 of 48 articles by views in journal of analytical toxicology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Drug facilitating sexual assault (DFSA) corresponds to sexual activity occurring whereas the victim is unable to express consent due to the action of drug. Although use of sedative and amnesic drug in DFSA such as benzodiazepines and gamma-hydroxybutyrate (GHB) is widely described in the medical literature, there is a lack of information regarding the involvement of amphetamine derivatives in this context, particularly synthetic cathinones. Herein, we report a case of a 19-year-old woman who presents herself into the emergency department following an acute alcoholic intoxication and a suspected DFSA after going in a nightclub. The emergency toxicological screening on the plasma and urine of the patient, performed through liquid chromatography coupled to high resolution tandem mass spectrometry (LC-HRMS) on target and non-target mode and with gas chromatography coupled to high resolution mass spectrometry (GC-HRMS) enabled the detection of 4-bromomethcathinone (4-BMC), a new psychoactive substance (NPS) of the cathinone family. The demethylated and reduced metabolites of the drug were also found in both plasma and urine. No other substance was identified except ethanol which was quantified in gas chromatography–flame ionization detection (GC-FID) and diazepam with its metabolites, this last one having been administrated in the emergency department. As far as we know, this report described the first case of DFSA involving this halogenated derivative of cathinone and consequently, highlights the need for toxicologists to systematically investigate with specific analytical methods the potential presence of NPS in case of DFSA.
Reference Key
openalex_W7166875667 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Schiestel Thomas, Magny Romain, Minka Hilary, Langrand Jérôme, Houzé Pascal, Labat Laurence
Journal journal of analytical toxicology
Year 2026
DOI
10.1093/jat/bkag058
URL
https://doi.org/10.1093/jat/bkag058
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.